Samir Abdelmagid, Ph.D.

2006 Temple University, Philadelphia, PA, United States 
Cell Biology
"Samir Abdelmagid"


Sign in to add mentor
Fayez F. Safadi grad student 2006 Temple University
 (Characterization and regulation of osteoactivin expression in osteoblasts.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sondag GR, Mbimba TS, Moussa FM, et al. (2016) Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling. Experimental & Molecular Medicine. 48: e257
Zhou X, Moussa FM, Mankoci S, et al. (2016) Orthosilicic acid, Si(OH)4, stimulates osteoblast differentiation in vitro by upregulating miR-146a to antagonize NF-κB activation. Acta Biomaterialia
Frara N, Abdelmagid SM, Tytell M, et al. (2016) Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping. Bmc Musculoskeletal Disorders. 17: 34
Frara N, Abdelmagid SM, Sondag GR, et al. (2016) Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo. Journal of Cellular Physiology. 231: 72-83
Abdelmagid SM, Sondag GR, Moussa FM, et al. (2015) Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function. The Journal of Biological Chemistry. 290: 20128-46
Abdelmagid SM, Barbe MF, Safadi FF. (2015) Role of inflammation in the aging bones. Life Sciences. 123: 25-34
Abdelmagid SM, Sondag GR, Moussa FM, et al. (2015) Mutation in osteoactivin promotes receptor activator of NFκB ligand (RANKL)-mediated osteoclast differentiation and survival but inhibits osteoclast function Journal of Biological Chemistry. 290: 20128-20146
Faruqi T, Dhawan N, Bahl J, et al. (2014) Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders. Biomed Research International. 2014: 670842
Geldenhuys WJ, Abdelmagid SM, Gallegos PJ, et al. (2014) Parkinson's disease biomarker: a patent evaluation of WO2013153386. Expert Opinion On Therapeutic Patents. 24: 947-51
Abdelmagid SM, Belcher JY, Moussa FM, et al. (2014) Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro. The American Journal of Pathology. 184: 697-713
See more...